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Aims: We investigated insulin action (insulin sensitivity index, ISI) and insulin secretion
(oral disposition indices, DIo) and studied metabolic, demographic and lifestyle-related risk
factors for type 2 diabetes and insulin action, in the largest non-European immigrant group
to Sweden, immigrants from Iraq and native Swedes.
Methods: Population-based, cross-sectional study conducted 2010–2012 including residents
30–75 years of age born in Iraq or Sweden, in whom oral glucose tolerance tests were
performed and sociodemography and lifestyle behaviors were characterized.
Results: In Iraqis compared to Swedes, ISI was more impaired (76.9 vs. 102.3, p < .001)
whereas corrected insulin response CIR was higher (226.6 vs. 188.6, p = .016). However,
insulin secretion was inadequate given the substantial insulin resistance, as indicated by
lower DIo indices in Iraqis than in Swedes (DIo 12,712.9 vs. 14,659.2, p < .001). The crude
ethnic difference in ISI was not offset by traditional risk factors like waist circumference,
body mass index or family history of diabetes.
In Iraqis, ISI conveyed somewhat higher odds of type 2 diabetes than in Swedes (odds
ratio OR 0.98, 95% CI 0.97–0.99) vs. OR 0.95, 0.92–0.99), as indicated by an interaction between
country of birth and ISI (Pinteraction = .044).
Conclusion: This study reports ethnic differences in the contribution of insulin action to type
2 diabetes. Our data suggests that the impaired insulin action observed in immigrants from
the Middle East to Sweden is not fully explained by established risk factors.
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Since the 1940s, Sweden has adopted an open-door policy on
immigration, offering almost unparalleled healthcare, educa-
tion and employment opportunities to immigrants who
acquire legal residence within the country. Fifteen percent
of the Swedish population is comprised of immigrants, of
which the second largest group is from Iraq [1]. One of the
most multicultural regions of Sweden is the area in and
around the southern Swedish city of Malmo¨, where almost
9000 of the 300,000 inhabitants are from Iraq. Recently the
population based MEDIM study (Impact of Migration and
Ethnicity on Diabetes In Malmo¨) have shown that immigrants
from Iraq have a twice as high prevalence of type 2 diabetes
(11.6 vs. 5.8%, p < .001) [2]. This is in consistency with previous
studies showing that migration and urbanization are estab-
lished risk factors for type 2 diabetes, and that immigrants
from the Middle East to Sweden have a high prevalence of type
2 diabetes [3]. This high prevalence is thought to be a
consequence of obesity (body mass index (BMI) > 30 kg/m2),
which is highly prevalent in non-European immigrants [4].
A recent study has reported ethnic differences in insulin
secretion and action related to ethnic background with a
higher insulin sensitivity in Japanese than Northern Eur-
opeans Caucasians whereas Northern Europeans presented
with better beta cell response to glucose [5]. However, the beta
cell response relative to the degree of insulin resistance was
similar in Japanese and Caucasians and this study concluded
that main determinants for ethnic differences in metabolic
profile are body mass index and adipose tissue [5].
Still, little is known about the metabolic, lifestyle, socio-
economic and heritable risk factors that underlie the
observation that type 2 diabetes is highly prevalent amongst
Middle Eastern immigrants to Northern Europe. To increase
knowledge of early mechanisms that contribute to type 2
diabetes and define the modifiable and non-modifiable risk
factors for type 2 diabetes in immigrant populations of Middle
Eastern descent living in Western countries, studies on insulin
secretion and action are warranted and necessary for design
and successful implementation of optimal preventive inter-
ventions against diabetes in these populations. Hence, in the
current report from the MEDIM study, we aimed to (1)
investigate insulin action and secretion (2) study risk factors
associated with type 2 diabetes and (3) investigate the
contribution of metabolic-, demographic- and lifestyle-related
risk factors for impaired insulin action (insulin sensitivity
index, ISI) in immigrants from Iraq, with comparisons to
native Swedes.
2. Subjects
Citizens of Malmo¨ born in Iraq aged 30–75 years were
randomly selected from the census register and invited by
mail and phone to participate in a population-based survey.
We aimed to recruit Swedish participants matched for sex and
age distributions living in the same geographical area in
Malmo¨. People with severe physical or mental illness or
disabilities were excluded from the study. To minimize cohorteffects and assessment biases, examinations were conducted
within a relatively short timeframe (February 1, 2010 through
December 31, 2012). A flow chart describing the recruitment of
MEDIM participants is described previously [6].
3. Materials and methods
3.1. Physical examination
Trained Swedish- and Arabic-speaking research nurses con-
ducted standard physical examinations. Assessment of
standard physical examinations and clinical variables such
as blood pressure, height, weight, waist circumferences, and
BMI was performed as described previously [7].
Abdominal obesity was defined as a waist circumference of
94 cm in men and 80 cm in women, as recommended for
Middle Eastern and Caucasian populations by the Interna-
tional Diabetes Federation/American Heart Association/Na-
tional Heart Lung and Blood Institute [8].
3.2. Blood samples and oral glucose tolerance test
Participants were instructed not to eat or drink anything but
water and not to use tobacco after 10 pm the day before
testing; they were also asked to bring a record of their current
medications to the examination. The following morning, a 75-
g oral glucose tolerance test (OGTT) was performed. Blood
samples were collected prior to glucose loading and at 30, 60,
90 and 120 min thereafter; glucose was measured in fresh
plasma from venous whole blood immediately after sampling
using a photometer (HemoCue AB, A¨ngelholm, Sweden) as
described previously [7]. Serum insulin, cholesterol, triglycer-
ide (p-TG), high-density lipoprotein (p-HDL) and low-density-
lipoprotein (p-LDL) levels were determined as previously
described [7]. Serum insulin levels were determined using a
radioimmunoassay (Access# Ultrasensitive Insulin, Beckman
Coulter, USA) [9] and c-peptide was measured with a one-step
immunometric sandwich-method using an electrochemilu-
miniscence immunoassay (ECLI) based on a ruthenium (Ru)
derivative (Roche Diagnostics, Mannheim, Germany). High
sensitive c-reactive protein (hs-CRP) was measured by a
commercial kit, according to the manufacturer’s instructions
(Roche Diagnostics, Mannheim, Germany). HbA1c was esti-
mated by high-pressure liquid chromatography (HPLC) with a
VARIANTTM TURBO Hemoglobin A1c Kit 2.0 (Bio-Rad).
Normal glucose tolerance (NGT) was considered in parti-
cipants with fasting glucose level of <6.1 mmol/L and 2-
hplasma glucose level of <7.8 mmol/L. Impaired fasting
glucose (IFG) was defined as a fasting plasma glucose level
of 6.1 mmol/L and <7.0 mmol/L and a 2-h plasma glucose
level of <7.8 mmol/L [10]. Impaired glucose tolerance (IGT) was
defined as a fasting plasma glucose level of <6.1 mmol/L and a
2-h plasma glucose level of 7.8 mmol/L and <11.1 mmol/L
[10] and impaired glucose regulation (IGR) was defined as IFG
in combination with IGT. IFG, IGT and IGR are in this paper
referred to as ‘prediabetes’.
New cases of type 2 diabetes were confirmed by a fasting
plasma glucose level of 7.0 mmol/L and/or by a 2-h plasma
glucose level of 11.1 mmol/L. If only one glucose value was
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 0 5 ( 2 0 1 4 ) 7 9 – 8 7 81pathologic, the OGTT was repeated on another day within 2
weeks with the same fasting procedures. Two values exceed-
ing these thresholds were needed for diagnosis [10]. Partici-
pants with previously known diabetes confirmed by
medication with oral hypoglycaemic agents and/or insulin,
or by a fasting glucose level of 7.0 mmol/L, did not undergo
an OGTT.
Insulin sensitivity index (ISI), corrected insulin response (CIR) and
oral disposition index (DIo) were assessed using the Matsuda
indices that were calculated from the OGTT results as follows:
ISI ¼ 10; 000= ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ½ðf-glcðmmol=LÞ  f-insulinðmIE=LÞÞ  ðmeanp
OGTT glc conc: ðmmol=LÞ  mean OGTT insulin conc: ðmIE=LÞÞ
[11].
CIR, is a measure of glucose-stimulated insulin secretion at
30 min of OGTT and provides an estimation of beta-cell
function and was calculated as follows: We have tried to
clarify this in the revised version.
CIR = (100  insulin at 30 min (mIE/L)/(glc30 (mmol/
L)  (glc30 – 3.89 mmol/L)) [12] and requiring that glucose at
30 min (glc30) > 4.44 mmol/L and glc30 > f-glc [13].
DIo provides an estimate of beta-cell function adjusted for
insulin resistance and takes the degree of insulin sensitivity
into account as CIR is driven both by glucose and insulin
sensitivity. DIo is calculated as CIR multiplied by ISI [14].
3.3. Questionnaires
Information on lifestyle habits, previous diagnosis of diabetes,
current medication, family history of diabetes (in biological
parents and/or siblings) and sociodemography was collected
in interviews by Arabic- and Swedish-speaking nurses using
structured questionnaires in Swedish and Arabic. All ques-
tionnaires were translated and back-translated by two
independent professional translators with Arabic as their
native language [7].Fig. 1 – Insulin secretion (CIR), in relation to insulin sensitivity 
Sweden.First-degree family history of diabetes was considered as
the presence of diabetes in biological parents, siblings and/or
children: FH no first-degree relatives, FH+ one or more first-
degree relatives with diabetes.
Smoking habits: Non-smokers included never-smokers and
participants who had stopped smoking more than 6 months
previously. All others were considered active smokers [15].
Alcohol consumption: Participants drinking alcohol were
considered alcohol consumers, regardless of how often or
how much they stated they drank.
Hours physically active/week: Physical activity (PA) was
estimated using questions developed by the Swedish National
Board of Health and Welfare to estimate time spent physically
active [16]. Time spent doing non-strenuous PA (e.g., walking,
cycling or gardening) and strenuous PA (e.g., jogging, swim-
ming, basketball or football) was estimated by the participants
in minutes. Time spent doing strenuous PA was multiplied by
two and then added to time spent doing non-strenuous PA
[16]. Total minutes per week were transformed to hours per
week.
Economic difficulties: difficulties in paying for food, rent or
bills on one or several occasions during the last 12 months [1].
Education level was categorized as (1) high school or less
(HS) or (2) above HS.
3.4. Statistical analysis
Analyses were performed using STATA IC/12.1. Skewed
variables were log10-transformed before analysis to approxi-
mate normal distributions. Least squares means were derived
after age and sex adjustment using linear regression, whereas
differences in proportions were adjusted for age and sex using
logistic regression. Associations with type 2 diabetes were
assessed using multivariate logistic regression analysis with
original units (Table 2a) and units standardized within
ethnicity (z-scores, Table 2b); these data are expressed asindex (ISI) in participants without diabetes born in Iraq or
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Associations with ISI were estimated using multivariate linear
regression analysis; these data are expressed as b coefficients
with 95% CIs (Table 3). In the multivariate model (Table 3),
regression coefficients (beta b) for the continuous independent
variables were standardized to a unit variance (per 1 standard
deviation (SD)), in strata of ethnicity and sex.
All tests were two-sided and a p-value of <.05 was
considered statistically significant.Table 1 – Characteristics of citizens of Malmo¨ born in Iraq and
Variable Normal glucose tolerance 
Iraq
N = 884
Sweden
N = 511
p 
Age (years) 44.2 (8.9) 47.4 (10.6) <.001 
Age at diabetes
onset (years)
– – 
Male sex, n (%) 520 (58.8) 266 (52.1) .014 
First degree history
of diabetes, n (%)
415 (46.9) 209 (27.6) <.001 
Waist circumference
men (cm)
97.6 (10.2) 95.4 (10.9) .002 
Waist circumference
women (cm)
91.2 (10.1) 86.8 (13.1) <.001 
Body mass index
(BMI) (kg/m2)
28.7 (4.3) 26.4 (4.2) <.001 
Abdominal obesity (men 94 cm;
women 80 cm)
651 (73.6) 314 (61.4) <.001 
Fasting glucose (mmol/L) 5.3 (.4) 5.3 (.4) .237 
30 min glucose (mmol/L) 7.8 (1.5) 7.6 (1.5) .001 
2-h glucose (mmol/L) 5.2 (1.3) 5.2 (1.3) .282 
Mean glucose 0, 30, 60,
120 min (mmol/L)
6.5 (0.9) 6.2 (0.9) .001 
Fasting insulin (mIE/L) 10.7 (6.7) 8.3 (5.9) <.001 
30 min insulin (mIE/L) 72.5 (54.1) 51.4 (34.6) <.001 
Mean insulin, 0, 30, 60,
120 min (mIE/L)
55.2 (36.2) 39.0 (25.6) <.001 
C-peptide (nmol/l) .80 (.30) .66 (.30) <.001 
Total cholesterol (mmol/L)a 5.0 (0.9) 5.3 (1.1) <.001 
p-LDL (mmol/L)a 3.3 (0.8) 3.4 (0.9) .043 
p-HDL (mmol/L)a 1.3 (0.3) 1.5 (0.4) <.001 
p-TG (mmol/L)a 1.6 (0.9) 1.2 (0.8) <.001 
Hs-CRP (mg/L) 2.7 (3.3) 2.1 (3.3) .002 
Systolic blood pressure (mmHg)b 126 (15.6) 132 (18.4) <.001 
Diastolic blood pressure (mmHg)b 77 (9.9) 80 (10.9) <.001 
Hours physically active/week 1.9 (2.1) 4.1 (2.4) <.001 
Smokers, n (%) 216 (24.4) 132 (25.8) .358 
Alcohol consumers, n (%) 166 (18.8) 417 (81.6) <.001 
Education level  HS, n (%) 248 (28.1) 76 (14.9) .001 
Econ. diff.  once the last
12 months, n (%)
467 (52.8) 79 (15.5) .015 
Data presented in means (standard deviation, SD), numbers (percentages
groups were adjusted for age and sex using linear regression models (
groups (but for male sex and family history of diabetes) were studied us
All tests were two-sided and a p-value of <.05 was considered statistica
Abbreviations: Econ. diff., economic difficulties; CIR, corrected insulin res
high sensitive C-reactive protein; HS, high school; IFG, impaired fasting g
insulin sensitivity index; LDL, low density lipoprotein; SD, standard dev
a Differences also adjusted for treatment with medication lowering chol
b Differences also adjusted for blood pressure lowering medication.In order to minimize the multiple testing burden, interac-
tions were considered only when the included marginal
effects were significant.
In the regression model Table 2, adjusting for BMI in a
univariate model increased the risk of type 2 diabetes.
However, when waist circumference was added in the model,
BMI contributed with reduced odds of type 2 diabetes and
hence BMI was excluded because its collinearly with waist
circumference (VIF = 4.1). Multicollinearity was assessed using Sweden in relation to glucose tolerance state.
IFG, IGT or IGR Type 2 diabetes
Iraq
N = 348
Sweden
N = 198
p Iraq
N = 162
Sweden
N = 44
p
48.1 (9.3) 53.1 (11.2) <.001 53.5 (9.3) 58.5 (9.7) .002
– – 47.6 (9.7) 53.4 (11.9) .001
192 (55.2) 105 (53.0) .629 105 (64.8) 28 (63.6) .885
199 (57.2) 63 (31.8) <.001 109 (67.3) 18 (40.9) .001
100.6 (9.8) 101.5 (11.1) .894 105.5 (11.6) 106.5 (13.8) .677
94.0 (10.8) 92.9 (14.1) .146 102.2 (11.4) 104.4 (15.2) .366
29.9 (4.4) 28.7 (5.0) .001 31.4 (5.1) 30.9 (6.1) .987
287 (82.5) 156 (78.8) .067 143 (88.3) 39 (88.6) .693
6.1 (.5) 6.2 (.6) .236 8.7 (2.8) 8.6 (3.1) .326
9.1 (1.7) 8.8 (1.8) .021 11.9 (2.2) 13.1 (4.2) .306
7.6 (2.2) 7.2 (2.2) .001 12.7 (3.9) 15.3 (5.7) .093
8.3 (1.9) 7.9 (1.3) .001 11.7 (2.2) 13.5 (4.2) .054
13.4 (9.3) 11.2 (8.2) .005 14.8 (10.8) 14.8 (14.4) .596
59.9 (40.7) 53.0 (49.7) .114 42.3 (36.9) 42.5 (35.0) .811
63.2 (40.5) 51.0 (44.9) .001 53.6 (35.6) 44.9 (33.0) .479
.89 (.37) .86 (.36) .096 .93 (.39) .96 (.51) .503
4.8 (0.9) 5.1 (0.9) .003 4.6 (1.3) 4.7 (1.1) .337
3.1 (0.8) 3.2 (0.8) .551 2.9 (1.0) 2.9 (0.9) .533
1.2 (0.3) 1.4 (0.4) <.001 1.1 (0.3) 1.4 (0.5) .005
1.5 (1.0) 1.3 (0.8) .022 1.9 (1.1) 1.6 (0.7) .119
3.3 (5.4) 2.9 (3.0) .139 4.3 (5.9) 3.9 (2.9) .926
132 (17.3) 141 (20.7) <.001 138 (17.9) 150 (21.1) .003
80 (10.6) 84 (12.2) .010 80 (11.3) 85 (10.3) .007
1.8 (2.0) 3.9 (2.6) <.001 1.9 (2.1) 3.3 (1.9) .001
78 (22.4) 51 (25.8) .154 40 (24.7) 10 (22.7) .733
54 (15.5) 163 (82.3) <.001 33 (20.4) 34 (77.3) <.001
86 (24.7) 53 (26.8) .593 50 (30.9) 14 (31.8) .888
164 (47.1) 30 (15.2) .072 83 (51.2) 5 (11.4) <.001
) or medians (interquartile range, IQR). Differences in means between
for continuous variables) while differences in proportions between
ing logistic regression adjusting for age and gender.
lly significant.
ponse; DIo, disposition index; HDL, high density lipoprotein; Hs-CRP,
lucose; IGT, impaired glucose tolerance; IQR, interquartile range; ISI,
iation; TG, triglycerides.
esterol levels (i.e., statins or similar medication).
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considered an issue, as VIF values in the final multivariate
regression models were <3.5.
3.5. Ethical considerations
All participants provided written informed consent and the
Ethics Committee at Lund University approved the study
(application nos. 2009/36 and 2010/561). This investigation
conforms to the principles outlined in the Declaration of
Helsinki [17].
4. Results
4.1. Characteristics of the study population in relation to
glucose tolerance
In Iraqi (n = 1398) compared to Swedish (n = 757) participants,
type 2 diabetes was twice as prevalent (11.6 vs. 5.8%, p < .001)
and diabetes onset occurred more than six years earlier (Table
1). The prevalence of family history was positively correlated
with the degree of glucose intolerance and was twice as
frequent in Iraqis compared with Swedes across the full
spectrum of glucose intolerance (Table 1).
Insulin action (as estimated by ISI) as well as beta cell
function estimated from insulin response relative to the
degree of insulin resistance (DIo) were generally lower in Iraqis
as compared to Swedes (ISI 76.9 vs. 102.3, p < .001 (mmol/
L mIE/L)1; DIo 12,712.9 vs. 14,659.2 (mmol/L mmol/L mmol/L),
p < .001). Irrespective of the adequacy of ISI, in participants
without type 2 diabetes, insulin secretion (as estimated by CIR)
was generally higher in immigrants from Iraq (Fig. 1). Although
ISI, CIR and DIo generally decreased with state of glucose
intolerance, ISI as well as beta cell function (DIo) were lower in
the normoglycaemic and prediabetic stages in Iraqis vs.
Swedes (Table 1, Fig. 2).
Further, normoglycaemic Iraqis presented a less advanta-
geous lipid profile and higher body fat measurements (waistTable 2a – Associations between type 2 diabetes and diabetes 
Swedes expressed in original units as odds ratios (OR) with 9
between country of birth and Insulin Sensitivity Index, Pinterac
Risk factors 
OR 
Age (years) 1.03 
Male sex 0.64 
Waist circumference (cm) 1.05 
Insulin Sensitivity Index, (mmol/L mIE/L)1 0.98 
Corrected insulin responsea, (mIE/L mmol/L1 mmol/L1) 0.97 
Family history of diabetes (yes/no) 1.05 
Associations were assessed using multivariate regression analysis adjust
insulin response. Table was also adjusted for the dichotomous variables
included in the model due to collinearity with waist circumference, vari
Bold-faced numbers are statistically significant.circumference and BMI) compared to Swedes (Table 1). In all
glucose tolerance stages, immigrants from Iraq were less
physically active and had a higher socioeconomic burden than
ethnic Swedes (Table 1).
In a subset of participants with normal waist circumfer-
ence (Iraqis n = 304, Swedes n = 239; waist circumference
<94 cm in men and <80 cm in women [8]), ISI (age and sex
adjusted data) was more severely impaired (106.6 vs.
149.6 mmol/L mIE/L, p < .001), DIo lower (14,933 vs.
18,215 mmol/L mmol/L mmol/L, p = .022) and p-TG higher
(1.4 vs. 0.9 mmol/L, p < .001) in immigrants from Iraq vs.
native Swedes. Similar results were seen in non-obese
participants (BMI < 25 kg/m2).
4.2. ISI, CIR and associations with type 2 diabetes
Studying the odds of type 2 diabetes, adjusting for age, sex,
family history of diabetes, BMI and waist circumference, in
Iraqis, ISI conveyed higher standardized odds of type 2
diabetes than in Swedes (Table 2a); the difference between
the magnitude of these relationships was confirmed by a
statistically significant interaction between country of birth
and ISI (Pinteraction = .044). There was no interaction between
country of birth and CIR. Data standardized within the strata
of ethnicity did not change the outcome of our data (Table 2b).
4.3. Ethnic background and association with insulin
action, ISI, Table 3
In a stepwise regression model we studied factors associated
with higher ISI in the total population. The crude difference in
ISI according to ethnicity remained significant even when
adjusting for metabolic-, anthropometric-, and lifestyle
factors. The addition of lipoproteins in the last step of the
model reduced the coefficient substantially, but did not offset
the difference in ISI related to country of birth. We also
observed interactions between country of birth and p-TG
(Pinteraction < .001) and between FH+ and p-TG (Pinteraction = .018)
that were associated with ISI.associated risk factors in immigrants from Iraq and native
5% confidence intervals (CI). There was an interaction
tion = .044.
Type 2 diabetes Type 2 diabetes
Born in Iraq Born in Sweden
N = 1144 N = 666
R2 = .42 R2 = .45
95% CI OR 95% CI
0.98 1.07 1.03 0.97 1.10
0.26 1.57 0.90 0.25 3.27
1.01 1.10 1.05 0.99 1.12
0.97 0.99 0.95 0.92 0.99
0.96 0.98 0.98 0.97 0.99
0.46 2.41 1.58 0.43 5.85
ing for age, waist circumference, insulin sensitivity index, corrected
 male sex and family history of diabetes. Body mass index was not
ance inflation factor (VIF) = 4.1.
Table 2b – Associations between type 2 diabetes and diabetes associated risk factors in immigrants from Iraq and native
Swedes expressed in standardized units (mean = 0; SD = z-scores) as odds ratios (OR) with 95% confidence intervals (CI).
Risk factors Type 2 diabetes Type 2 diabetes
Born in Iraq Born in Sweden
N = 1148 N = 644
R2 = .43 R2 = .43
OR 95% CI OR 95% CI
Age, per 1 SD 1.03 0.99 1.08 1.04 0.98 1.10
Waist circumference, per 1 SD 1.05 1.01 1.09 1.06 0.99 1.12
Insulin Sensitivity Index, per 1 SD 0.98 0.97 0.99 0.96 0.93 0.99
Corrected insulin responsea, per 1 SD 0.97 0.96 0.98 0.98 0.97 0.99
Associations were assessed using multivariate regression analysis adjusting for age, waist circumference, insulin sensitivity index, corrected
insulin response.
a CIR only included cases where the glucose level at 30 min was >4.44 mmol/l and greater than the fasting glucose level (1).
Bold-faced numbers are statistically significant.
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Although the participants in this study were somewhat older
compared to the eligible background population (Iraqis by 1.7Table 3 – Factors associated with higher insulin sensitivity in
associations expressed as b coefficients with 95% confidence 
Variable Model 1 
N = 1915 
R2 = .05 
Born in Sweden Reference 
Born in Iraq S.120 
S.146 to S.095 
Age (years), per 1 SD 
Female sex 
Male sex 
Family history of diabetes 
No 
Yes 
Waist circumference, per 1 SD 
Body mass index (kg/m2), per 1 SD 
Hours physically active/week, per 1 SD 
Current tobacco smoking 
High sensitive CRP (mg/L), per 1 SD 
Plasma triglycerides (mmol/L), per 1 SD 
Plasma high density lipoprotein (mmol/L), per 1 SD 
b-Coefficients were standardized (SD) per 1 SD unit variance for the co
strata of ethnicity and sex.
Collinearity waist circumference and BMI < 3.5.
Bold-faced numbers are statistically significant.years, 95% CI 0.9–2.5, p < .001; Swedes 4.5 by years, 95% CI 3.5–
5.6, p < .001), the prevalence of self-reported diabetes in
participants vs. non-participants did not differ significantly
(data not shown).dex (ISI) in immigrants from Iraq and native Swedes,
intervals.
Model 2 Model 3 Model 4 Model 5
N = 1854 N = 1842 N = 1644 N = 1572
R2 = .09 R2 = .34 R2 = .36 R2 = .42
Reference Reference Reference Reference
S.111 S.120 S.122 S.117
S.137 to S.085 S.142 to S.097 S.146 to S.099 S.139 to S.094
S.022 .001 S.006 S.008
S.034 to S.009 S.011 to.011 S.017 to.006 S.020 to .003
Reference Reference Reference Reference
S.096 S.092 S.100 S.098
S.121 to S.071 S.113 to S.071 S.122 to S.077 S.120 to S.076
Reference Reference Reference Reference
S.043 S.021 S.023 S.018
S.068 to S.017 S.043 to .002 S.046 to .001 S.040 to .004
S.098 S.097 S.086
S.118 to S.078 S.118 to S.076 S.106 to S.065
S.051 S.049 S.039
S.071 to S.032 S.069 to S.028 S.059 to S.018
.013 .026
.008 to .018 .015 to .037
.028 .038
.002 to .054 .012 to .063
S.010
S.021 to .001
S.044
S.056 to S.032
.025
.012 to .037
ntinuous independent variables. Standardizations were done in the
Fig. 2 – Median level of insulin action and secretion estimated with Matsuda indices for insulin sensitivity index, ISI,
corrected insulin response, CIR, and oral disposition index, DIo, in participants born in Iraq or Sweden with normal glucose
tolerance, prediabetes (IFG, IGT or IGR) and type 2 diabetes, data presented with 95% CI.
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 0 5 ( 2 0 1 4 ) 7 9 – 8 7 855. Discussion
To the best of our knowledge, this is the first study to examine
metabolic risk factors for type 2 diabetes and insulin action in
an immigrant population from the Middle East (Iraq) to a
northern European country and compare these risk factors
with those observed in the native population. The key findings
of this study are that there are ethnic differences in the
relationship of insulin action with type 2 diabetes; our study
suggests that ethnic background modifies the effect of insulin
action on the risk of type 2 diabetes and further that theimpaired insulin action in this Arabic population is only partly
explained by excess waist circumference or other known risk
factors for insulin action.
5.1. Ethnic differences in insulin action and secretion as
risk factors for type 2 diabetes
A recent systematic review and meta-analysis reported ethnic
differences in the relationship between insulin sensitivity and
insulin secretion by comparing Caucasians with Africans and
East Asians [18]. Another study including 270 participants,
reported higher insulin sensitivity and lower insulin secretion
d i a b e t e s r e s e a r c h a n d c l i n i c a l p r a c t i c e 1 0 5 ( 2 0 1 4 ) 7 9 – 8 786in Japanese compared with Caucasians of Northern European
background [5]. In that study, disposition indices were similar
for Japanese and Caucasians at all glucose tolerance states,
indicating similar beta-cell response to glucose relative to the
degree of insulin resistance and that these differences were
ascribed differences in body composition [5]. Our larger data
set on the contrary indicate that in a Middle Eastern immigrant
population without type 2 diabetes, the beta cells are unable to
compensate for the substantial peripheral insulin resistance
by ramping up insulin secretion. This contrasts with our
findings in native Swedes and appears to be independent of
differences in body composition between ethnic groups.
Defining the mechanisms underlying these observations
would be an important focus of future research. However,
the metabolic characteristics of the leaner Iraqi participants in
this study resembles those seen in patients with non-alcohol
fatty liver disease (NAFLD) [19–21], which is a risk factor for
type 2 diabetes [22] and shares its genetic risk factors with
other intermediate metabolic risk factors such as impaired
insulin sensitivity and hypertriglyceridemia [20].
Another explanation for the higher degree of insulin
resistance in Iraqis compared with native Swedes in this
study may be increased intramyocellular fat that is often seen
in association with skeletal muscle insulin resistance [23]. Our
finding of an interaction between higher p-TG level and family
history influencing insulin action is in concordance with
recent studies reporting disturbed lipid metabolism and
skeletal muscle mitochondrial dysfunction in family histo-
ry-positive vs. family history-negative individuals [24,25].
5.2. Strengths and limitations
The major strengths of this study are that it was conducted in
Sweden, where health care, education, and employment are
equally accessible to immigrant and non-immigrant popula-
tions; thus, confounding and biases attributable to these
factors are likely to be less than in other study settings where
immigrant and native populations are compared. Our study is
population-based and represents a large fraction of the Iraqi
population in the region. It is also distinct from other studies of
this topic in that it includes detailed metabolic phenotyping
and assessments of lifestyle exposures. The study is limited by
the participation of more Iraqi men than women, which may
reflect attitudes toward scientific research and other gender-
specific sociocultural factors. We did not analyze liver
enzymes to test for NAFLD, however studies have reported
that most individuals with NAFLD have normal levels of liver
transaminases [26]. Another limitation is the cross-sectional,
observational design, making it difficult to draw conclusions
regarding causality in relation to type 2 diabetes as well as to
insulin secretion and action.
5.3. Conclusions
This study shows ethnic differences in the contribution of
insulin action and secretion to type 2 diabetes. Our data
suggest that the impaired insulin action observed in the
largest non-European immigrant group to Sweden, citizens
born in Iraqis not fully explained by traditional risk factors
such as body fat or family history of diabetes and that futureresearch should focus on identifying the mechanisms behind
this finding.
We conclude that Middle Eastern immigrant populations
born in Iraq are likely to benefit greatly from interventions
focused on improving insulin sensitivity, such as that
deployed by the Diabetes Prevention Program [27] and the
Finnish Diabetes Prevention Study [28].
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